27
Jan
PROFILEA biotech CEO’s favorite ‘F’ wordAt SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the course of autoimmune disease.Published Jan. 26, 2023Read Ira Spector's PharmaVoice Profile ...
Read More